Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-036-1 | CAS number: 77-54-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 15 August 2000 - 29 September 2000
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- (1997)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- [3R-(3α,3aβ,6α,7β,8aα)]-octahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-5-yl acetate
- EC Number:
- 201-036-1
- EC Name:
- [3R-(3α,3aβ,6α,7β,8aα)]-octahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-5-yl acetate
- Cas Number:
- 77-54-3
- Molecular formula:
- C17H28O2
- IUPAC Name:
- [3R-(3α,3aβ,6α,7β,8aα)]-octahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-5-yl acetate
Constituent 1
Method
- Target gene:
- Histidine gene
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Details on mammalian cell type (if applicable):
- CELLS USED- Source of cells: Dr. Bruce N. Ames, University of California, Berkeley, California, USAMEDIA USED- Type and identity of media including CO2 concentration if applicable:- Properly maintained: [yes/no]- Periodically checked for Mycoplasma contamination: [yes/no]- Periodically checked for karyotype stability: [yes/no)- Periodically 'cleansed' against high spontaneous background: [yes/no]
- Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver S9-mix
- Test concentrations with justification for top dose:
- Experiment 1:
- TA98, TA100, TA102 & TA1537 (with and without S9): 15, 50, 150, 500, 1500 and 5000 µg/plate
- TA1535 (without S9): 50, 150, 500, 1500 and 5000 µg/plate
- TA1535 (with S9): 15, 50, 150, 500 and 1500 µg/plate
Experiment 2:
- TA98 & TA100 (with and without S9): 50, 150, 500, 1500 and 5000 µg/plate
- TA102 (with and without S9): 15, 50, 150, 500, 1500 and 5000 µg/plate
- TA1535 & TA1537 (without S9): 50, 150, 500, 1500 and 5000 µg/plate
- TA1535 & TA1537 (with S9): 15, 50, 150, 500, 1500 and 5000 µg/plate
Experiment 3:
- TA102 (with S9): 15, 50, 150, 500, 1500 and 5000 µg/plate
The dose levels were chosen based on the outcome of an initial (cyto)toxicity test. - Vehicle / solvent:
- - Solvent used: DMSO
- Justification for choice of solvent: standard solvent
Controls
- Untreated negative controls:
- yes
- Remarks:
- (untreated plates)
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- mitomycin C
- other: 2-aminoanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 to 72 hours
NUMBER OF REPLICATIONS: Alleexperiments were performed in triplicate
DETERMINATION OF CYTOTOXICITY
- Method: assessment of the reduction in the number of revertant colonies and diminution of the background lawn - Rationale for test conditions:
- Standard plate incorporation test conditions.
- Evaluation criteria:
- A significant increase in number of mutant colonies is considered a mutagenic response. A dose-response relationship showing increasing numbers of mutant colonies with increasing dose levels supports this. An additional general rule is that two-fold (or more) increases in mean revertant numbers must be observed between the solvent control and a specific dose level.
- Statistics:
- An estimation of the statistical significance of the difference between the mean number of revertants in the negative controls and the plates at each dosage level was made using a X2-test (Mohn and Ellenberger, 1977).
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with
- Genotoxicity:
- ambiguous
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: Precipitation of the test compound on the plates was observed at 1500 and 5000 µg/plate.
RANGE-FINDING/SCREENING STUDIES: Initial toxicity test was performed to determine dose levels.
COMPARISON WITH HISTORICAL CONTROL DATA:
- The number of spontaneous revertants observed using each of the live strains was close to those previously established in the laboratory and was within the range obtained by Ames et al. (1975) as well as reported by De Serres and Shelby (1979).
ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Cytotoxicity was observed in the presence of S9-mix towards the strains TA1537 and TA102 at 5000 µg/plate and in the absence of S9-mix towards the strain TA102 at 5000 µg/plate.
Applicant's summary and conclusion
- Conclusions:
- Under the conditions of this study, the test substance was determined to be not mutagenic and does not need to be classified for mutagenicity in accordance with the criteria outline in Annex I of the CLP Regulation (1272/2008/EC).
- Executive summary:
The mutagenic activity of the substance was evaluated in accordance with OECD 471 (1997) and according to GLP principles. The test was performed according to the standard plate-incorporation assay, in the absence and presence of S9-mix. The dose levels were selected based on an initial toxicity test. Adequate negative and positive controls were included. A significant increase in the mutation frequency of the tester strain TA102 in the presence of a metabolic activation system was seen in one of three experiments. This was not observed in the absence of S9-mix. The substance did not induce a significant increase in the number of revertant colonies in any of the other S. typhimurium strains (TA1535, TA1537, TA98 and TA100), both in the absence and presence of S9-metabolic activation. The significant increase in mutation frequency for TA102 was only evident in 1 out of 3 tests which have been performed with a metabolizing system, not found to be dose-dependent and also not two-fold as compared to the solvent control. Also the mean mutant frequency at each of the dose levels was still within the historical control range for this strain. Based on this, the overall result for strain TA102 is considered negative, as well as for the other strains. Based on these results, the substance was found to be not mutagenic and does not need to be classified for mutagenicity in accordance with the criteria outline in Annex I of the CLP Regulation (1272/2008/EC).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)